Is the high price of drugs for rare diseases justified?

November 29, 2010

Afflicted with a rare blood disorder, Barry Katsof relies on an intravenous medication every two weeks that affords him the active lifestyle of his pre-symptom days almost a decade ago. The only problem is the drug therapy comes at a hefty price tag to taxpayers – $500,000 every year for the rest of his life. (The Globe and Mail)